Health
Study addresses glycosylation concerns in SARS-CoV-2 vaccine design – News-Medical.Net
An international team of researchers has found that glycosylation patterns are conserved across the native spike protein of severe acute respiratory syndrome coronavirus…
An international team of researchers has found that glycosylation patterns are conserved across the native spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – and the recombinant spike proteins made in laboratories for use in vaccines.
The spike protein, which SARS-CoV-2 uses to bind to and infect cells, is the main target of neutralizing antibodies following natural infection with the virus or vaccination.
A…
-
Noosa News19 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Business20 hours agoUp 105% in a year, are Pro Medicus shares still a good buy today?
-
Noosa News16 hours agoQueensland man sentenced to four years imprisonment after string of terror offences
-
Business18 hours agoEverything you need to know about the Coles dividend